Copyright
        ©The Author(s) 2004.
    
    
        World J Gastroenterol. Feb 1, 2004; 10(3): 309-318
Published online Feb 1, 2004. doi: 10.3748/wjg.v10.i3.309
Published online Feb 1, 2004. doi: 10.3748/wjg.v10.i3.309
            Table 1 Mast cells involved in non-allergic diseases in internal medicine.
        
    | Disease | Evidence | 
| Chronic obstructive | Mast cell hyperplasia in epithelia and | 
| pulmonary disease | bronchial glands[2,3], tryptase and histamine | 
| (COPD) | release in BALF[4] | 
| Cor pulmonale | Mast cell hyperplasia in bronchial and | 
| vascular tissues[5] | |
| Bronchiectasis | Increased numbers of degranulated mast | 
| cells in lung tissue, and higher tryptase | |
| concentrations in BALF[6] | |
| Acute respiratory | Mast cell hyperplasia[7] and degranulation[8] | 
| distress syndrome (ARDS) | |
| ronchiolitis obliterans- | Mast cell hyperplasia[9] and degranulation[10] | 
| organizing pneumonia | |
| Cystic fibrosis | Mast cell hyperplasia[11] and | 
| degranulation[12] in lung | |
| Interstitial lung diseases | Mast cell hyperplasia[13] and degranulation[14] | 
| Silicosis | Mast cell hyperplasia[15] | 
| Sarcoidosis | Mast cell hyperplasia[16], and | 
| degranulation[17] in lung | |
| Lung cancer | Mast cell hyperplasia[18] | 
| Tuberculosis | Mast cell degranulation[19] | 
| Gastritis | Mast cell hyperplasia[20] and degranulation[21] | 
| Peptic ulcer | Mast cell hyperplasia[22] and degranulation[23] | 
| Hepatocellular | Mast cell hyperplasia[24] | 
| carcinoma | |
| Ulcerative colitis | Mast cell hyperplasia[25,26] and degranulation[27] | 
| Crohn’s disease | Mast cell hyperplasia[28] and degranulation[29] | 
| Liver cirrhosis | Mast cell hyperplasia[30] | 
| Hepatitis | Mast cell hyperplasia[31,32] | 
| Pancreatitis | Mast cell hyperplasia and degranulation[33] | 
| Atherosclerosis | Mast cell hyperplasia[34] | 
| Myocardial infarction | Mast cell hyperplasia and degranulation[35,36] | 
| Congenital heart disease | Mast cell hyperplasia and subtype change[37] | 
| Myocarditis | Mast cell hyperplasia[38] | 
| Cardiomyopathy | Mast cell hyperplasia[39] and degranulation[40] | 
| Diabetes | Mast cell hyperplasia[41] | 
| Thyroiditis | Mast cell hyperplasia[42] | 
| Osteoporosis | Mast cell hyperplasia[43] | 
| Glomerulonephritis | Mast cell hyperplasia[44] | 
| Nephropathy | Mast cell hyperplasia[45] | 
| Multiple sclerosis | Mast cell hyperplasia[46] | 
| Rheumatoid arthritis | Mast cell degranulation[47] | 
| Osteoarthritis | Mast cell hyperplasia[48] | 
| Rheumatic arthritis | Mast cell hyperplasia[49] | 
- Citation: He SH. Key role of mast cells and their major secretory products in inflammatory bowel disease. World J Gastroenterol 2004; 10(3): 309-318
- URL: https://www.wjgnet.com/1007-9327/full/v10/i3/309.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i3.309

 
         
                         
                 
                 
                 
                 
         
                         
                         
                        